Dysarthria

This article is currently under review and may not be up to date. Please come back soon to see the finished work! (26/10/2020)

Original Editor - User Name
Top Contributors - Jacintha McGahan and Kim Jackson

Clinically Relevant Anatomy

Dysarthria pertains to a category of neurogenic speech disorders distinguished by anomaly in the strength, speed, availability, stableness, tone, or accuracy of movements necessary for breathing, phonatory, resonatory, articulatory, or prosodic features of speech creation.

These anomalies are the result of one or several sensorimotor issues, including weakness or paralysis, incoordination, involuntary movements, or immoderate, declined, or inconstant muscle tone. Dysarthria can negatively impact the comprehensibility of speech, realism of speech, or both. It is necessary to be aware that intelligence can be normal in some speakers with dysarthria. Dysarthria might co-exist with other neurogenic language, cognitive, and swallowing disorders.

Mechanism of Injury / Pathological Process

Damage to the nervous system causes hypotonicity in the muscles that create speech sounds. This may impact the muscles in one or several of the following areas:

• Face
• Lips
• Tongue
• Throat
• Upper respiratory tract

The neurological damage that can result in dysarthria can be from:

• Congenital: cerebral palsy, Chiari malformation, congenital suprabulbar palsy, syringomyelia, syringobulbia.
• Degenerative diseases: amyotrophic lateral sclerosis (ALS), Parkinson's disease, progressive supranuclear palsy, cerebellar degeneration, corticobasal degeneration, multiple system atrophy, Friedreich's ataxia, Huntington's disease, olivopontocerebellar atrophy, spinocerebellar ataxia, ataxia telangiectasia.
• Demyelinating and inflammatory diseases: multiple sclerosis, encephalitis, Guillain-Barré and associated autoimmune diseases,meningitis, multifocal leukoencephalopathy.
• Infectious diseases: acquired immune deficiency syndrome (AIDS), Creutzfeldt-Jakob disease, herpes zoster, infectious encephalopathy, central nervous system tuberculosis, poliomyelitis.
• Neoplastic diseases: central nervous system tumors; cerebral, cerebellar, or brainstem tumors; paraneoplastic cerebellar degeneration.
• Other neurologic conditions: hydrocephalus, Meige syndrome, myoclonic epilepsy, neuroacanthocytosis, radiation necrosis, sarcoidosis, seizure disorder, Tourette's syndrome, Chorea gravidarum
• Toxic/metabolic diseases: alcohol, botulism, carbon monoxide poisoning, central pontine myelinolysis, heavy metal or chemical toxicity, hepatocerebral degeneration, hypothyroidism, hypoxic encephalopathy, lithium toxicity, Wilson's disease.
• Trauma: traumatic brain injury, chronic traumatic encephalopathy, neck trauma, neurosurgical/postoperative trauma, skull fracture.
• Vascular Diseases: stroke (hemorrhagic or nonhemorrhagic), Moyamoya disease, anoxic or hypoxic encephalopathy, arteriovenous malformations.

Clinical Presentation

add text here relating to the clinical presentation of the condition

Diagnostic Procedures

add text here relating to diagnostic tests for the condition

Outcome Measures

add links to outcome measures here (see Outcome Measures Database)

Management / Interventions

add text here relating to management approaches to the condition

Differential Diagnosis

add text here relating to the differential diagnosis of this condition

Resources

add appropriate resources here